OGX-427 Data on Patients with Advanced Prostate Cancer Presented at the 2012 ASCO Annual Meeting

OncoGenex focuses on diverse molecular entities that target mechanisms of resistance and that have the potential to re-define treatment paradigms in a variety of cancers.